In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin

Journal of Microencapsulation

Volumn 29, Issue 1, 2012, Pages 1-8

  Huang, Xuan ^a   Huang, Xiong ^a   Jiang, Xiao Hong ^a   Hu, Fu Qiang ^b   Du, Yong Zhong ^b   Zhu, Qi Feng ^a   Jin, Cheng Sheng ^a  

^a JIAXING UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Chitosan; in vitro antitumour activity; in vitro release; Micelle; Podophyllotoxin; Stearic acid

Indexed keywords

PODOPHYLLOTOXIN; STEARIC ACID DERIVATIVE; STEARIC ACID G CHITOSAN OLIGOSACCHARIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHITOSAN; OLIGOSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TRANSPORT; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MICELLE; MICROENCAPSULATION; PARTICLE SIZE; POLYMERIZATION; ZETA POTENTIAL; CHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHITOSAN; HUMANS; MICELLES; OLIGOSACCHARIDES; PODOPHYLLOTOXIN; STEARIC ACIDS;

EID: 84855896711     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.621551     Document Type: Article

References (24)

1. Alessandro N, Noha MZ, Piero L, Suwipa U, Proramate S, Maria GR, Nicola T. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparti-cles: Systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res, 2009;26:1918-30.
2. Andres BS, Martina EK. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: Synthesis and evaluation of different chitosan-EDTA conjugates. J Control Rel, 1998;50:215-23.
3. Bedows E, Hatfield GM. An investigation of the antiviral activity of podophyllum peltatum. J Nat Prod, 1982;45:725-9. (Pubitemid 13180954)
4. Cui FY, Qian F, Yin CH. Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int J Pharm, 2006;316:154-61. (Pubitemid 43765702)
5. De Campos AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm, 2001;224:159-68. (Pubitemid 32706495)
6. Desbene S, Giorgi-Renault S. Drugs that inhibit tubulin polymerization: The particular case of podophyllotoxin and analogues. Curr Med Chem Anti-Cancer Agents, 2002;2:71-90. (Pubitemid 34649869)
7. Gordaliza M, Faircloth GT, Castro MA, San Feliciano A. Immunosuppressive cyclolignans. J Med Chem, 1996;39:2865-8. (Pubitemid 26240356)
8. Gordaliza M, Garcia PA, Miguel del Corral JM, Castro MA, Gómez-Zurita MA. Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon, 2004;44(4):441-59. (Pubitemid 39070644)
9. Hu FQ, Liu LN, Du YZ, Yuan H. Synthesis and antitumor activity of doxo-rubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials, 2009;30:6955-63.
10. Hu FQ, Ren GF, Yuan H, Du YZ, Zeng S. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B-Biointerfaces, 2006a;50:97-103. (Pubitemid 43946659)
11. Hu FQ, Zhao MD, Yuan H, You J, Du YZ, Zeng S. A novel chitosan oligo-saccharide-stearic acid micelles for gene delivery: Properties and in vitro transfection studies. Int J Pharm, 2006b;315:158-66. (Pubitemid 43674116)
12. Imbert TF. Discovery of podophyllotoxins. Biochimie, 1998;80:207-22. (Pubitemid 28206037)
13. Kim SY, Shin IG, Lee YM, Cho CS, Yong KS. Methoxy poly(ethylene glycol) and caprolactone amphiphilic block copolymeric micelle containing indomethacin: II. Micelle formation and drug release behaviours. J Control Rel, 1998;51:13-22. (Pubitemid 28064641)
14. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Rel, 1998;51:213-20. (Pubitemid 28252873)
15. Longstaff E, Von KG. Condyloma eradication: Self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations-an integrated safety assessment. Regul Toxicol Pharm, 2001;33:117-37. (Pubitemid 32466677)
16. Lopez-Perez JL, del Olmo E, de Pascual-Teresa B, Abad A, San Feliciano A. Synthesis and cytotoxicity of hydrophobic esters of podophyllotoxins. Bioorg Med Chem Lett, 2004;14:1283-6. (Pubitemid 38232667)
17. Qin L, Xue M, Wang W, Zhu R, Wang S, Sun J, Zhang R, Sun X. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin. Int J Pharm, 2010;388:223-30.
18. Takeshi K, Hiroyuki I, Chie K, Mitsuomi H, Gen S. Preparation of lipopoly-saccharide derived from pantoea agglomerans labeled with fluorescence as a tracer for kinetics analysis. Anticancer Res, 2010;30:3151-7.
19. Thongborisute J, Tsuruta A, Kawabata Y, Takeuchi H. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. J Drug Target, 2006;14:147-54. (Pubitemid 43878823)
20. Varum KM, Ottoy MH, Smidsord O. Acid hydrolysis of chitosans. Carbohydr Polym, 2001;46:89-98. (Pubitemid 32487092)
21. Vladimir L, Matthias P. Microquantification of cellular and in vitro F-actin by rhodamine phalloidin fluorescence enhancement. Anal Biochem, 1998;264(2):185-90.
22. Ye YQ, Yang FL, Hu FQ, Du YZ, Yuan H, Yu HY. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin. Int J Pharm, 2008;352:294-301.
23. You J, Hu FQ, Du YZ, Yuan H. Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel. Biomacromolecules, 2007;8:2450-6. (Pubitemid 47316985)
24. Zhu RR, Qin LL, Wang M, Wu SM, Wang SL, Zhang R, Liu ZX, Sun XY, Yao SD. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology, 2009;20:55702-8.